Zynga (ZNGA), ResMed (RMD), Intrepid Potash (IPI), Trustmark (TRMK), Web.com (WWWW), Cablevision (CVC), Varian Medical (VRA) were upgraded or downgraded by analysts.
ResMed (RMD) upgraded to Strong Buy from Buy at Feltl.Feltl upgraded ResMed based on valuation. Price target is $35.
Intrepid Potash (IPI) upgraded to Outperform from Sector Perform at Scotia Capital Price target $28.
Trustmark (TRMK) initiated with a Buy at BB&T Target $25.
Targacept (TRGT) downgraded to Market Perform from Outperform at Leerink.Leerink downgraded Targacept after the company announced a second failed depression treatment study. The firm lowered its target range for shares to $6-$7.
Web.com (WWWW) initiated with an Overweight at JP Morgan Target $18.
Varian Medical (VRA) initiated with an Above Average at Caris Target $72.
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/